1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow ANCA-associated Vasculitis: new trials by email Literature Review of ANCA-associated Vasculitis trials Research Report on ANCA-associated Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis BDB-001 injection, Cyclophosphamide, Glucocorticoids - ANCA-associated Vasculitis | Phase 1 / Phase 2 | Completed | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 93 | 2022-02-22 | 2025-08-07 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)
Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Immune System Diseases (1) · Skin Diseases (1) · Skin Diseases, Vascular (1) · Skin and Connective Tissue Diseases (1) · Systemic Vasculitis (1) · Vascular Diseases (1) · Vasculitis (1)
BDB001 (1) · Cyclophosphamide (1) · Glucocorticoids (1) · Prednisone (1)
Staidson (Beijing) Biopharmaceuticals Co., Ltd (1)
China (1)